Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


João Gama Marques has a total of 252 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reconsidering the Association Between Epilepsy and Schizophrenia

    by Karim Abdel Aziz, Inês D’ALmeida, Martin M. Schumacher, Josef Finsterer, João Gama-Marques

    Was not provided for this article.

  • Open Access

    A 20-Year Longitudinal Study of Homelessness Among 333 Psychiatric Patients in Portugal: From Initial Episodes to Chronic Trajectories

    by Joana Henriques-Calado, Nathalia Garcia, João Gama-Marques

    Background: Homelessness is closely related to psychiatric disorders, substance abuse, and premature mortality; however, in-depth analyses of long-term trajectories are lacking. Aims: The objective was to analyze psychiatric diagnoses, clinical patterns and survival outcomes of homelessness trajectories during a 20-year follow-up. Method: A retrospective sample of 333 psychiatric patients experiencing homelessness in Portugal. Cox survival analyses defined the cohorts: Recent (⩽1 year; n = 92), Early-stage (1–5 years; n = 52), Prolonged (5–15 years; n = 93), and Persistent (>15 years; n = 96). Analyses included analysis of variance (ANOVA), Chi-square tests, and logistic regression. Results: Mortality was 31.2%, decreasing after 18 years of homelessness, indicating a survivor effect. Recent cohort and younger patients, and those with alcohol misuse, anxiety, and personality disorders had minimal hospitalization. Early-stage and Prolonged groups had the highest mortality (50%), linked to alcohol-related disorders and organic psychosis, mainly in Prolonged. Persistent cohort, with the longest psychiatric follow-up (18.8 years), more hospitalizations, and higher comorbidity with drug use and intellectual disability, had the lowest mortality (14.6%) and the highest mean age at death (67.3 years). Unspecified psychosis, substance use, and intellectual disability were the key predictors of Persistent group. Alcohol use, psychosis, and personality disorders influenced survival varying by cohort. Conclusions: Patient psychiatric homelessness cohorts have heterogeneous trajectories for clinical, sociodemographic, service use, and survival. Early and mid-stages of homelessness show higher mortality. Findings highlight the Persistent cohort as long-term homelessness survivors. It is stressed that the duration of homelessness is a critical determinant of diagnostic patterns, comorbidities, and survival outcomes, which require differentiated psychiatric and social interventions tailored to cohort-specific risks among people experiencing homelessness.

  • The interictal psychoses of epilepsy: A systematic review of case reports

    by Inês D'ALmeida, João Gama‐Marques

    Interictal psychosis has long been described as a neuropsychiatric condition secondary to epilepsy. However, there is no chronological relationship with seizures. It differs from schizophrenia since negative symptoms are less prominent, and deterioration of the patient's personality is uncommon. Forced normalization, an antagonistic relation between seizures and psychosis, may be observed, and it is sometimes called alternating or alternative psychosis when there is no electroencephalogram available. The treatment relies on a balance between antipsychotics and antiseizure medications. Surgery is still controversial. This review aims to analyze the existing literature regarding case reports of interictal psychosis. The search performed in the PubMed database for the terms ((psycho*[Title/Abstract]) OR (schizo*[Title/Abstract])) AND ((interictal [Title/Abstract]) OR (inter‐ictal [Title/Abstract])) presented 703 articles, 112 of which met the eligibility criteria. Forty‐six other studies from other sources were included. Eligible articles were sorted according to their format into case reports and non‐case reports. Sixty‐nine patients, on average 34.7 ± 12.9 years old, were studied. More than half (50.7%) displayed neuropsychiatric comorbidities, with psychoses (23.2%) and head trauma (15.9%) being the most reported. Fourteen (20.3%) patients were mistakenly diagnosed with primary psychosis. Twenty (29.0%) had a left hemisphere focus, the majority in the temporal lobe. The largest single subgroup of patients whose neuroimaging exams were available (17.4%) had no abnormalities. A significant percentage (62.3%) presented abnormal electroencephalograms, 12 of those with episodes of forced normalization (17.4%). The delay between epilepsy and interictal psychosis was 13.8 ± 10.2 years (Median 13.5 years). Many patients have their symptoms treated as primary, and forced normalization also complicates the treatment. It is urgent to implement guidelines for diagnosis, theragnosis, and prognosis of this fascinating entity.


  • Open Access

    Underprescription of Clozapine: A Narrative Review Regarding ‘Clozaphobia’

    by Rafael Brito Castro, Joaquim J. Ferreira, João Gama‐Marques

    This review aims to examine the appropriateness of the term ‘clozaphobia’ to characterise the obstacles contributing to the underprescription of clozapine (CLZ). English‐language, peer‐reviewed studies addressing clinicians', patients' and/or carers' attitudes toward CLZ were considered eligible for full‐text review. In May 2025, a search was conducted using the keywords clozapine, clozaphobia , fear* , underus* , underprescri* , underutiliz* , and barrier* , restricted to titles and abstracts on PubMed, Web of Science, Scopus, and Cochrane. A total of 362 records were retrieved, and 30 records were identified through backward citation searching. After screening, 53 studies were eligible for review. This review identified several barriers to CLZ use, which were grouped into three broad domains: clinician‐related, medication‐ and patient‐related, and administrative‐related barriers. Key barriers included difficulties in recognising Treatment‐Resistant Schizophrenia (TRS) and identifying candidates for CLZ, lack of training and confidence, negative attitudes toward CLZ, variability in treatment pathways, concerns about CLZ's adverse effects, and challenges in convincing carers of the need for CLZ, insufficient resources, unclear professional roles, and fragmentation of services. The vast majority of identified barriers stem from misconceptions or negative attitudes toward CLZ, which unjustifiably limit patient access to this effective treatment, and can be addressed through the implementation of existing facilitating strategies. In such contexts, the term clozaphobia seems appropriate and its use may help to raise awareness and promote critical reflexion on this subject. With the end of the clozapine risk evaluation and mitigation strategy, it is now time to push society to start producing higher dose pills and a long‐acting injectable version of clozapine.


  • Open Access

    Barriers to and facilitators of healthcare access among people experiencing homelessness: a systematic scoping review

    by Daniela Gorski, Filipa Alves da Costa, Ricardo Fuertes, João Gama-Marques, Lara Tavoschi, Fernanda S. Tonin

    Background: People experiencing homelessness (PEH) face complex social and economic challenges that increase their risk of poor health. This study aimed to identify and synthesize key barriers to and facilitators of healthcare access from the perspective of PEH to inform more equitable and sustainable health strategies. Methods: A systematic scoping review was conducted in accordance with the guidelines of the Cochrane Collaboration and the Joanna Briggs Institute and was reported following the Preferred Reporting Items for Scoping Reviews (PRISMA-ScR). A PubMed, Embase and Web of Science search was conducted in January 2025 using terms related to homelessness, healthcare, and interventional and observational studies. A manual search of the reference lists of the included studies was also performed via conventional search engines. Two reviewers independently classified the relevance of the extracted studies according to predefined eligibility criteria. Any discrepancies were solved by a third reviewer. The final list of studies enabled extraction of barriers to and facilitators of access to healthcare, subsequently classified according to the socioecological model. Results: A total of 79 studies ( n = 51,110 PEH) published between 1989 and 2024, mostly from the United States of America (USA) ( n = 48; 63.3%), were included. Interventions most frequently addressed general healthcare ( n = 25; 31.6%), treatment of specific conditions ( n = 23; 29.1%) and sexual and reproductive healthcare ( n = 7; 8.9%). Common individual-level barriers included health related-beliefs and concerns ( n = 43), cognitive and behavioral health challenges ( n = 28), and substance use ( n = 18), whereas increased health awareness ( n = 13) facilitated healthcare utilization. At the interpersonal level, social stigma ( n = 51) and negative provider attitudes ( n = 31) were prominent barriers, whereas strong social networks ( n = 34) supported engagement. Institutional-level barriers included bureaucracy ( n = 21) and lack of service integration ( n = 20); conversely, continuity of care ( n = 8) and process simplification ( n = 7) acted as facilitators. Community-level barriers involved limited-service availability ( n = 22), direct ( n = 34) and indirect costs ( n = 19); facilitators were centered on structure of the health service ( n = 16). At the policy level, limited resources and service offer ( n = 7), as well as undocumented situations by PEH ( n = 4) were key barriers; strategically located services ( n = 7) facilitated healthcare utilization. Conclusion: Improving healthcare for PEH requires multilevel, person-centered strategies that address structural, interpersonal, and individual barriers while streamlining access through inclusive public policy. Review registration: International Prospective Register of Systematic Reviews (PROSPERO): CRD42025635835.


  • Open Access

    Secondary psychotic syndromes should be excluded before assuming idiopathic digital “Folie à trois”

    by João Gama-Marques

    Secondary psychotic syndromes should be excluded before assuming idiopathic digital folie à trois